The Strategic Medical Countermeasures Program (SMCP), on behalf of the Canadian Forces Health Services Group (CF H Svcs Gp) has a requirement for Potassium Iodide tablets for use as a thyroid blocking agent for use in nuclear emergencies which involve the release of radioiodine.
The Contract Period will be from contract award to 31 March 2030.
The Crown retains the rights to negotiate with suppliers on any procurement.
Documents may be submitted in either official language of Canada.
Policy on Reciprocal Procurement: This solicitation of offers is open only to Canadian suppliers (if subject to any international trade agreement(s)): and to Suppliers of an applicable trading partner.
Applicable trade agreements:
Canadian Free Trade Agreement
Canadian-Colombia Free Trade Agreement
Canada-Honduras Free Trade Agreement
Canada-Panama Free Trade Agreement
Canada-Korea Free Trade Agreement
Canada-Peru Free Trade Agreement
Canada-Chili Free Trade Agreement